Pharm-Olam International Releases Results of 2005 Client Satisfaction Survey
Revealing continuing improvement in levels of customer satisfaction and loyalty, Pharm-Olam International Ltd. (POI), a multi-national CRO to pharmaceutical, biotechnology, and medical device industries, has released the most recent results of its formal survey.
Houston, TX, December 09, 2005 --(PR.com)-- Revealing continuing improvement in levels of customer satisfaction and loyalty, Pharm-Olam International Ltd. (POI), a multi-national CRO to pharmaceutical, biotechnology, and medical device industries, has released the most recent results of its formal survey. The survey was conducted by an independent research firm with extensive experience working with multi-national CROs and revealed that overall client satisfaction with the company’s services is at an all time high. The clients were asked to evaluate the effectiveness of Pharm-Olam’s service and staff and measured how the company met its clients’ expectations.
One of the key factors that attributed to the success of the survey is the degree of participation from the clients. “When 74% of all customers volunteer to participate, you are seeing POI’s partnership approach to business in action. Naturally we're very pleased with the positive feedback from our customers, but as we constantly strive to provide superior service it is very important to know where you can improve,” said Madeline Ducate, VP of Global Services. “Client satisfaction is extremely important to us because over 70% of our customers are repeat business, and over 50% of our new accounts were from referrals.”
Among the top reasons why clients chose Pharm-Olam as their CRO were: a proven track record, technical expertise in the area of study, reacting quickly to provide a rescue plan for studies done by other companies, and good communication skills.
Pharm-Olam International Ltd. offers a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From pre-clinical to Phase IV, POI is focused on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines. Pharm-Olam has been conducting clinical trials for over 10 years with our own local employees in more than 20 countries. For general inquiries about Pharm-Olam’s services please contact Iain Gordon, Director of Global Business Development, at igordon@pharm-olam.com.
###
One of the key factors that attributed to the success of the survey is the degree of participation from the clients. “When 74% of all customers volunteer to participate, you are seeing POI’s partnership approach to business in action. Naturally we're very pleased with the positive feedback from our customers, but as we constantly strive to provide superior service it is very important to know where you can improve,” said Madeline Ducate, VP of Global Services. “Client satisfaction is extremely important to us because over 70% of our customers are repeat business, and over 50% of our new accounts were from referrals.”
Among the top reasons why clients chose Pharm-Olam as their CRO were: a proven track record, technical expertise in the area of study, reacting quickly to provide a rescue plan for studies done by other companies, and good communication skills.
Pharm-Olam International Ltd. offers a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From pre-clinical to Phase IV, POI is focused on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines. Pharm-Olam has been conducting clinical trials for over 10 years with our own local employees in more than 20 countries. For general inquiries about Pharm-Olam’s services please contact Iain Gordon, Director of Global Business Development, at igordon@pharm-olam.com.
###
Contact
Pharm-Olam International
Eric Rupprath
+1 (713) 463-8075
www.pharm-olam.com
Eric Rupprath
+1 (713) 463-8075
www.pharm-olam.com
Contact